Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature

Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning

(2013) Emma Watz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autoimmune Hematological Diseases after Allogeneic Hematopoietic Stem Cell Transplantation in Children: An Italian Multicenter Experience

(2013) Maura Faraci et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature

(2013) Jordina Rovira et al.   TRANSFUSION MEDICINE REVIEWS

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

(2012) T. Daikeler et al.   BLOOD

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

(2012) John Koreth et al.   JOURNAL OF CLINICAL ONCOLOGY

Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib

(2011) L-M Poon et al.   BONE MARROW TRANSPLANTATION

Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation

(2011) Jun Nakata et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

(2011) A. M. Gomez et al.   JOURNAL OF IMMUNOLOGY

Anémies hémolytiques auto-immunes : diagnostic biologique et nouvelles approches thérapeutiques

(2011) D. Rigal et al.   TRANSFUSION CLINIQUE ET BIOLOGIQUE

Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma

(2010) K. Frohlich et al.   ANNALS OF THE RHEUMATIC DISEASES

Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib

(2010) K. R. Carson et al.   BLOOD

Bortezomib: friend or foe of hemolytic anemia?

(2010) Constantin A Dasanu   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML

(2009) M Rokicka et al.   BONE MARROW TRANSPLANTATION

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies

(2009) Nicola P. Klein et al.   VACCINE

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE